Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE). / Pappot, Helle; Bæksted, Christina; Knoop, Ann; Mitchell, Sandra A.; Nissen, Aase; Johansen, Christoffer.
I: Breast Journal, Bind 25, Nr. 2, 2019, s. 269-272.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients—Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE)
AU - Pappot, Helle
AU - Bæksted, Christina
AU - Knoop, Ann
AU - Mitchell, Sandra A.
AU - Nissen, Aase
AU - Johansen, Christoffer
PY - 2019
Y1 - 2019
N2 - The Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed by the National Cancer Institute to capture patient self-reports of symptomatic toxicities during cancer treatment. The aim of this short communication is to describe the design of a national study, which examine the effect of using patients’ electronic PRO-CTCAE reporting with real-time feedback to clinicians on treatment events for breast cancer patients receiving adjuvant chemotherapy. The study's end-points are defined as dose reduction, hospitalization, and febrile neutropenia. This is the first report on the impact of PRO-CTCAE in a national breast cancer population during chemotherapy treatment.
AB - The Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed by the National Cancer Institute to capture patient self-reports of symptomatic toxicities during cancer treatment. The aim of this short communication is to describe the design of a national study, which examine the effect of using patients’ electronic PRO-CTCAE reporting with real-time feedback to clinicians on treatment events for breast cancer patients receiving adjuvant chemotherapy. The study's end-points are defined as dose reduction, hospitalization, and febrile neutropenia. This is the first report on the impact of PRO-CTCAE in a national breast cancer population during chemotherapy treatment.
KW - adjuvant chemotherapy
KW - breast cancer
KW - patient reported outcome
KW - PRO-CTCAE
KW - toxicity
U2 - 10.1111/tbj.13204
DO - 10.1111/tbj.13204
M3 - Journal article
C2 - 30761667
AN - SCOPUS:85061456159
VL - 25
SP - 269
EP - 272
JO - Breast Journal
JF - Breast Journal
SN - 1075-122X
IS - 2
ER -
ID: 230247160